Valeant Pharmaceuticals International Inc. expands into the consumer eye care space with the $8.7 billion acquisition of Bausch + Lomb Inc., an innovator of dietary supplements for ocular health.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?